A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus Infection
Open Access
- 26 May 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 163 (10), 1220-1226
- https://doi.org/10.1001/archinte.163.10.1220
Abstract
AFTER INTRODUCTION of highly active antiretroviral treatment (HAART), morbidity and mortality of human immunodeficiency virus (HIV) infection have declined.1 However, many patients find it difficult to comply with long-term HAART,2,3 especially if they experience adverse effects.4,5Keywords
This publication has 2 references indexed in Scilit:
- Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4 + and CD8 + T-Cell Responses: Relationship to Viral Load in Untreated HIV InfectionJournal of Virology, 2001
- Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000HIV Research & Clinical Practice, 2000